Position in GEHC
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,398,316,620
-$163,047,765 QoQ
Shares Held
37,467,843
+4.1% QoQ
Ownership
8.24%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2
of 1,221 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in GEHC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BlackRock, Inc. holds $63,343,633,098 across 119 Medical Devices names. GEHC ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
152,563,476 | $13,843,609,801 | |
| 2 | MDT |
Medtronic plc
|
114,020,787 | $8,919,846,156 | |
| 3 | SYK |
Stryker Corp
|
27,414,742 | $8,631,257,363 | |
| 4 | BSX |
Boston Scientific Corp
|
129,680,916 | $5,534,781,484 | |
| 5 | EW |
Edwards Lifesciences Corp
|
58,789,433 | $5,318,092,100 | |
| 6 | DXCM |
Dexcom Inc
|
38,244,137 | $2,575,742,616 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
This page
|
37,467,843 | $2,398,316,620 | |
| 8 | STE |
STERIS plc
|
8,820,889 | $1,857,414,586 |
All Filings in GEHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,398,316,620 | 37,467,843 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,561,364,385 | 35,984,327 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,029,714,295 | 36,938,726 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,744,792,189 | 36,548,498 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,655,481,265 | 35,850,969 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,085,715,524 | 38,232,134 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,949,498,649 | 37,727,023 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,402,872,417 | 36,258,630 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||